Patents Assigned to MESOTEX, INC.
  • Publication number: 20220389384
    Abstract: The present disclosure provides processes for isolating target nucleated cells, such as fetal mesenchymal stem cells, from non-nucleated red blood cells, populations of cells obtainable by the processes of the disclosure, and methods of using isolated targeted nucleated cells methods and their progeny for detecting fetal abnormalities and stem cell therapy.
    Type: Application
    Filed: January 14, 2022
    Publication date: December 8, 2022
    Applicant: MESOTEX, INC.
    Inventor: Giammaria SITAR
  • Publication number: 20210072227
    Abstract: The present disclosure provides processes for the separation of nucleated cells from non-nucleated red blood cells, populations of cells obtainable by the processes of the disclosure, and devices and kits useful in the processes of the disclosure.
    Type: Application
    Filed: February 27, 2020
    Publication date: March 11, 2021
    Applicant: MESOTEX, INC.
    Inventor: Giammaria SITAR
  • Publication number: 20190153392
    Abstract: The present disclosure provides processes for isolating target nucleated cells, such as fetal mesenchymal stem cells, from non-nucleated red blood cells, populations of cells obtainable by the processes of the disclosure, and methods of using isolated targeted nucleated cells methods and their progeny for detecting fetal abnormalities and stem cell therapy.
    Type: Application
    Filed: April 6, 2017
    Publication date: May 23, 2019
    Applicant: MESOTEX, INC.
    Inventor: Giammaria SITAR
  • Publication number: 20180120295
    Abstract: The present disclosure provides processes for the separation of nucleated cells from non-nucleated red blood cells, populations of cells obtainable by the processes of the disclosure, and devices and kits useful in the processes of the disclosure.
    Type: Application
    Filed: April 29, 2016
    Publication date: May 3, 2018
    Applicant: MESOTEX, INC.
    Inventor: Giammaria SITAR